These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15537564)

  • 21. Diagnosis and management of diastolic dysfunction and heart failure.
    Satpathy C; Mishra TK; Satpathy R; Satpathy HK; Barone E
    Am Fam Physician; 2006 Mar; 73(5):841-6. PubMed ID: 16529092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Brunner-La Rocca HP; Buser PT; Schindler R; Bernheim A; Rickenbacher P; Pfisterer M;
    Am Heart J; 2006 May; 151(5):949-55. PubMed ID: 16644310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).
    Adams KF; Fonarow GC; Emerman CL; LeJemtel TH; Costanzo MR; Abraham WT; Berkowitz RL; Galvao M; Horton DP;
    Am Heart J; 2005 Feb; 149(2):209-16. PubMed ID: 15846257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center].
    Zoghi M; Duygu H; Güngör H; Nalbantgil S; Yilmaz GM; Tülüce K; Ozerkan F; Akilli A; Akin M
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):255-9. PubMed ID: 18676300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA; Gheorghiade M
    Cardiol Clin; 2008 Feb; 26(1):23-40, vi. PubMed ID: 18312903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acutely decompensated heart failure: characteristics of hospitalized patients and opportunities to improve their care.
    Sarmento PM; Fonseca C; Marques F; Ceia F; Aleixo A
    Rev Port Cardiol; 2006 Jan; 25(1):13-27. PubMed ID: 16623353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes.
    Mebazaa A; Gheorghiade M; Piña IL; Harjola VP; Hollenberg SM; Follath F; Rhodes A; Plaisance P; Roland E; Nieminen M; Komajda M; Parkhomenko A; Masip J; Zannad F; Filippatos G
    Crit Care Med; 2008 Jan; 36(1 Suppl):S129-39. PubMed ID: 18158472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic changes before acute heart failure episodes in patients with advanced systolic left ventricular dysfunction.
    Ghio S; Serio A; Mangiavacchi M; Kjellström B; Valsecchi S; Vicini I; Campana C; Gasparini M; Gronda E; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):799-804. PubMed ID: 18607244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blocker therapy in patients with heart failure in the urban setting: moving beyond clinical trials.
    Estep JD; Mehta SK; Uddin F; King L; Toto KH; Nelson LL; Dries DL; Yancy CW; Drazner MH
    Am Heart J; 2004 Dec; 148(6):958-63. PubMed ID: 15632878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological treatment of chronic heart failure according to the 2005 guidelines of the European Society of Cardiology.
    Voors AA; van Veldhuisen DJ
    Minerva Cardioangiol; 2005 Aug; 53(4):233-9. PubMed ID: 16177668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile].
    Grigorian Shamagian L; Varela Román A; Pedreira Pérez M; Gómez Otero I; Virgós Lamela A; González-Juanatey JR
    Rev Esp Cardiol; 2006 Feb; 59(2):99-108. PubMed ID: 16540030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.
    Soriano CJ; Ridocci F; Estornell J; Jimenez J; Martinez V; De Velasco JA
    J Am Coll Cardiol; 2005 Mar; 45(5):743-8. PubMed ID: 15734620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
    Krum H; Ashton E; Reid C; Kalff V; Rogers J; Amarena J; Singh B; Tonkin A
    J Card Fail; 2007 Feb; 13(1):1-7. PubMed ID: 17338996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
    Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
    J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ; Ottesen MM; Rask-Madsen C; Andersen PK; Rosthøj S; Torp-Pedersen C; Køber L
    Int J Cardiol; 2005 Sep; 104(2):184-9. PubMed ID: 16168812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary disease.
    Rutten FH; Vonken EJ; Cramer MJ; Moons KG; Velthuis BB; Prakken NH; Lammers JW; Grobbee DE; Mali WP; Hoes AW
    Am Heart J; 2008 Sep; 156(3):506-12. PubMed ID: 18760133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.